NASDAQ : COGT
Cogent Biosciences, Inc. — Financial statements
Healthcare · Biotechnology · United States
Last price 31.96 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 5.55B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Selling, General & Admin | 98.37M | 63.58M | 43.28M | 34.38M | 26.21M | 19.64M |
| Research & Development | 290.72M | 269.78M | 232.66M | 173.75M | 121.63M | 55.91M |
| Operating Expenses | 389.09M | 333.36M | 275.94M | 208.13M | 147.84M | 75.55M |
| Operating Income | -389.09M | -333.36M | -275.94M | -208.13M | -147.84M | -75.55M |
| Interest Expense | -5.18M | -3.06M | ||||
| Interest & Investment Income | 24.43M | 14.69M | 18.09M | 13.08M | 3.99M | 467.00K |
| Other Non Operating Income (Expenses) | -160.00K | -20.00K | 1.99M | 2.64M | 3.61M | 2.81M |
| EBT Excluding Unusual Items | -370.00M | -321.76M | -255.86M | -192.41M | -140.24M | -72.27M |
| Other Unusual Items | -7.18M | -7.18M | ||||
| Pretax Income | -377.18M | -328.94M | -255.86M | -192.41M | -140.24M | -72.27M |
| Earnings From Continuing Operations | -328.94M | -255.86M | -192.41M | -140.24M | -72.27M | |
| Net Income | -377.18M | -328.94M | -255.86M | -192.41M | -140.24M | -72.27M |
| Net Income to Common | -377.18M | -328.94M | -255.86M | -192.41M | -140.24M | -72.27M |
| Shares Outstanding (Basic) | 155.05M | 128.97M | 103.94M | 79.66M | 58.83M | 38.73M |
| Shares Outstanding (Diluted) | 155.05M | 128.97M | 103.94M | 79.66M | 58.83M | 38.73M |
| EPS (Basic) | -2.43 | -2.55 | -2.46 | -2.42 | -2.38 | -1.87 |
| EPS (Diluted) | -2.43 | -2.55 | -2.46 | -2.42 | -2.38 | -1.87 |
| Free Cash Flow | -309.24M | -266.00M | -208.36M | -156.42M | -125.50M | -60.48M |
| Free Cash Flow Per Share | -2.00 | -2.06 | -2.00 | -1.96 | -2.13 | -1.56 |
| EBITDA | -386.46M | -330.80M | -273.49M | -205.86M | -147.00M | -75.40M |
| D&A For EBITDA | 2.64M | 2.56M | 2.45M | 2.27M | 842.00K | 147.00K |
| EBIT | -389.09M | -333.36M | -275.94M | -208.13M | -147.84M | -75.55M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 181.17M | 312.01M | 98.17M | 53.23M | 139.89M | 219.68M |
| Short-Term Investments | 611.13M | 588.75M | 188.91M | 212.48M | 119.39M | |
| Cash & Short-Term Investments | 792.30M | 900.76M | 287.08M | 265.71M | 259.28M | 219.68M |
| Prepaid Expenses | 12.52M | 9.59M | 9.39M | 5.06M | 4.43M | 2.95M |
| Restricted Cash | 1.25M | |||||
| Total Current Assets | 804.82M | 910.36M | 296.47M | 270.77M | 264.97M | 222.63M |
| Property, Plant & Equipment | 27.37M | 23.54M | 26.56M | 30.34M | 31.10M | 4.48M |
| Long-Term Investments | 7.46M | |||||
| Other Long-Term Assets | 2.35M | 3.72M | 4.86M | 4.86M | 4.75M | 4.98M |
| Total Assets | 834.55M | 937.61M | 327.90M | 313.44M | 300.81M | 232.09M |
| Accounts Payable | 7.49M | 9.50M | 12.01M | 10.65M | 5.84M | 3.48M |
| Accrued Expenses | 49.00M | 46.16M | 41.76M | 25.69M | 17.48M | 7.97M |
| Current Portion of Leases | 1.49M | 1.55M | 1.56M | 1.39M | 1.42M | 2.32M |
| Other Current Liabilities | 1.32M | 6.75M | 373.00K | 441.00K | 2.10M | 3.29M |
| Total Current Liabilities | 59.30M | 63.95M | 55.71M | 38.17M | 26.85M | 17.08M |
| Long-Term Debt | 223.46M | 222.90M | ||||
| Long-Term Leases | 19.32M | 14.36M | 15.90M | 17.47M | 18.23M | 831.00K |
| Other Long-Term Liabilities | 90.00K | 33.00K | ||||
| Total Liabilities | 302.16M | 301.24M | 71.61M | 55.63M | 45.08M | 17.91M |
| Common Stock | 171.00K | 161.00K | 110.00K | 86.00K | 70.00K | 44.00K |
| Additional Paid-In Capital | 1.85B | 1.73B | 1.00B | 801.06M | 601.15M | 399.71M |
| Retained Earnings | -1.38B | -1.19B | -859.48M | -603.62M | -411.21M | -270.97M |
| Comprehensive Income & Other | -770.00K | 355.00K | 447.00K | 246.00K | -104.00K | |
| Total Common Equity | 467.63M | 546.98M | 145.69M | 197.77M | 189.91M | 128.78M |
| Shareholders' Equity | 532.39M | 636.37M | 256.29M | 257.80M | 255.74M | 214.18M |
| Total Liabilities & Equity | 834.55M | 937.61M | 327.90M | 313.44M | 300.81M | 232.09M |
| Total Debt | 244.26M | 238.80M | 17.47M | 18.85M | 19.65M | 3.15M |
| Net Cash (Debt) | 548.04M | 661.97M | 269.61M | 254.32M | 239.63M | 216.53M |
| Net Cash Per Share | 3.53 | 5.13 | 2.59 | 3.19 | 4.07 | 5.59 |
| Filing Date Shares Outstanding | 173.57M | 161.05M | 110.54M | 103.91M | 69.95M | 45.81M |
| Total Common Shares Outstanding | 171.64M | 161.05M | 110.54M | 86.12M | 69.89M | 43.81M |
| Working Capital | 745.52M | 846.40M | 240.76M | 232.60M | 238.12M | 205.56M |
| Book Value Per Share | 2.72 | 3.40 | 1.32 | 2.30 | 2.72 | 2.94 |
| Tangible Book Value | 467.63M | 546.98M | 145.69M | 197.77M | 189.91M | 128.78M |
| Tangible Book Value Per Share | 2.72 | 3.40 | 1.32 | 2.30 | 2.72 | 2.94 |
| Machinery | 10.91M | 10.08M | 9.54M | 6.93M | 1.21M | |
| Construction In Progress | 763.00K | 41.00K | 27.00K | 482.00K | 646.00K | |
| Leasehold Improvements | 2.46M | 2.46M | 2.44M | 1.78M | 408.00K |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -377.18M | -328.94M | -255.86M | -192.41M | -140.24M | -72.27M |
| Depreciation & Amortization | 4.81M | 4.58M | 4.35M | 3.59M | 5.88M | 1.99M |
| Other Amortization | 1.10M | 601.00K | ||||
| Loss (Gain) From Sale of Assets | 134.00K | 8.00K | ||||
| Asset Writedown & Restructuring Costs | -396.00K | |||||
| Loss (Gain) From Sale of Investments | -3.36M | -1.96M | -7.62M | -5.17M | -1.64M | |
| Stock-Based Compensation | 60.37M | 46.08M | 39.74M | 30.62M | 18.37M | 11.69M |
| Other Operating Activities | 7.18M | 7.18M | -1.70M | -1.36M | -343.00K | |
| Change in Accounts Payable | -9.14M | -2.51M | 1.36M | 4.81M | 2.36M | 2.75M |
| Change in Other Net Operating Assets | 8.54M | 10.52M | 10.24M | 6.63M | -1.61M | -2.58M |
| Operating Cash Flow | -307.55M | -264.44M | -207.79M | -153.62M | -118.64M | -58.76M |
| Capital Expenditures | -1.70M | -1.55M | -573.00K | -2.80M | -6.86M | -1.72M |
| Investment in Securities | -498.30M | -397.97M | 38.85M | -95.03M | -117.86M | |
| Investing Cash Flow | -499.99M | -399.53M | 38.28M | -97.82M | -124.72M | -1.72M |
| Long-Term Debt Issued | 272.39M | |||||
| Long-Term Debt Repaid | -54.63M | |||||
| Net Debt Issued (Repaid) | 168.47M | 217.76M | ||||
| Issuance of Common Stock | 783.41M | 752.20M | 214.45M | 174.24M | 174.36M | 39.26M |
| Repurchase of Common Stock | -48.90M | -48.90M | ||||
| Other Financing Activities | -41.45M | -42.82M | -10.70M | -10.80M | -1.28M | |
| Financing Cash Flow | 861.53M | 878.23M | 214.45M | 163.54M | 163.56M | 37.98M |
| Net Cash Flow | 53.99M | 214.26M | 44.94M | -87.91M | -79.80M | -22.51M |
| Free Cash Flow | -309.24M | -266.00M | -208.36M | -156.42M | -125.50M | -60.48M |
| Free Cash Flow Per Share | -2.00 | -2.06 | -2.00 | -1.96 | -2.13 | -1.56 |
| Levered Free Cash Flow | -186.15M | -152.49M | -115.91M | -86.68M | -67.08M | -31.78M |
| Unlevered Free Cash Flow | -184.01M | -151.18M | -115.91M | -86.68M | -67.08M | -31.78M |
| Cash Interest Paid | 3.60M | 2.02M | ||||
| Change in Working Capital | -599.00K | 8.01M | 11.60M | 11.44M | 751.00K | 176.00K |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 5.38B | 5.40B | 861.60M | 506.41M | 807.97M | 341.92M |
| Enterprise Value | 4.84B | 5.18B | 644.48M | 272.78M | 604.79M | 228.12M |
| Last Close Price | 31.02 | 35.52 | 7.80 | 5.88 | 11.56 | 8.58 |
| PB Ratio | 11.39 | 8.49 | 3.36 | 1.96 | 3.16 | 1.60 |
| P/TBV Ratio | 11.51 | 9.88 | 5.91 | 2.56 | 4.25 | 2.65 |
| Debt / Equity Ratio | 0.46 | 0.38 | 0.07 | 0.07 | 0.08 | 0.01 |
| Net Debt / Equity Ratio | -1.03 | -1.04 | -1.05 | -0.99 | -0.94 | -1.01 |
| Net Debt / EBITDA Ratio | 1.42 | 2.00 | 0.99 | 1.24 | 1.63 | 2.87 |
| Net Debt / FCF Ratio | 1.77 | 2.49 | 1.29 | 1.63 | 1.91 | 3.58 |
| Quick Ratio | 13.36 | 14.09 | 5.15 | 6.96 | 9.66 | 12.86 |
| Current Ratio | 13.57 | 14.23 | 5.32 | 7.09 | 9.87 | 13.04 |
| Return on Equity (ROE) | -109.74% | -73.70% | -99.54% | -74.94% | -59.69% | -32.20% |
| Return on Assets (ROA) | -43.84% | -32.93% | -53.78% | -42.35% | -34.68% | -19.55% |
| Return on Capital Employed (ROCE) | -50.20% | -38.20% | -101.40% | -75.60% | -54.00% | -35.10% |
| Earnings Yield | -7.84% | -6.09% | -29.70% | -38.00% | -17.36% | -21.14% |
| FCF Yield | -5.74% | -4.92% | -24.18% | -30.89% | -15.53% | -17.69% |
| Buyback Yield / Dilution | -37.58% | -24.09% | -30.48% | -35.41% | -51.89% | -249.52% |